banner
1
Yin YD#, Wang R, Zhuo C, Wang H, Wang MG, Xie CM, She DY, Yuan X, Wang RT, Cao B*, Liu YN*. Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study. J Thorac Dis. 2017; 9(10): 3774-3781. doi:10.21037/jtd.2017.09.75.
2
Xue C#, Wen M#, Bao L#, Li H, Li F, Liu M, Lv Q, An Y, Zhang X*, Cao B*. Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A. Front Immunol. 2017; 8. doi:10.3389/fimmu.2017.01054.
3
Cao B#*, Qu J-X#, Yin Y-D#, Eldere J Van#. Overview of antimicrobial options for M ycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J. 2017; 11(4): 419-429. doi:10.1111/crj.12379.
4
Li H#, Yang S, Gu L, Zhang Y, Yan X, Liang Z, Zhang W, Jia H, Chen W, Liu M, Yu K, Xue C, Hu K, Zou Q, Li L, Cao B*, Wang C. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respi Viruses. 2017; 11(4): 345-354. doi:10.1111/irv.12456.
5
Lee N#, Cao B, Ke C, Lu H, Hu Y, Tam CHT, Ma RCW, Guan D, Zhu Z, Li H, Lin M, Wong RYK, Yung IMH, Hung T-N, Kwok K, Horby P, Hui DSC, Chan MCW*, Chan PKS*. IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza. J Infect Dis. 2017; 216(1): 97-104. doi:10.1093/infdis/jix235.
6
Guo L#, Li G, Wang J, Zhao X, Wang S, Zhai L, Jia H, Cao B*. Suspicious outbreak of ventilator-associated pneumonia caused by Burkholderia cepacia in a surgical intensive care unit. Am J Infect Control. 2017. doi:10.1016/j.ajic.2017.01.024.
7
Shi SJ#, Li H, Liu M, Liu YM, Zhou F, Liu B, Qu JX, Cao B*. Mortality prediction to hospitalized patients with influenza pneumonia: PO 2 /FiO 2 combined lymphocyte count is the answer. Clin Respir J. 2017; 11(3): 352-360. doi:10.1111/crj.12346.
8
Li H#, Cao B*. Pandemic and Avian Influenza A Viruses in Humans: Epidemiology, Virology, Clinical Characteristics, and Treatment Strategy. Clin Chest Med. 2017; 38(1): 59-70. doi:10.1016/j.ccm.2016.11.005.
9
Liao K#, Chen Y#, Wang M, Guo P, Yang Q, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Hu Z, Chu Y, Chen S, Cao B, Su J, Gui B, Duan Q, Zhang S, Shao H, Kong H, Xu Y*. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China. Diagn Microbiol Infect Dis. 2017; 87(1): 45-48. doi:10.1016/j.diagmicrobio.2016.10.007.
10
刘智博#,曹彬*. 侵袭性念珠菌病的初始治疗:棘白菌素还是氟康唑? 中华内科杂志. 2017, 10; 56(10): 774-776.
11
郭丽萍#,曹彬*,徐潜,魏栋,刘聪,李刚,王书鹏,王建,邬巧玲,郝秀萍,赵霞,赵学军,王颖,王卫华,张璟,郑爱辉,郎琳娜,丁晶宏. 三起医务人员发生临床诊断水痘聚集性疫情的调查分析与预防控制效果. 中华医院感染学杂志. 2017; 27(9): 2152-2155.
12
唐可京,罗益锋,苏霞,贺蓓,时国朝,宋立强,文富强,吕晓菊,陈佰义,熊盛道,赵建平,张天托,周建英,俞云松,曹彬#,肖伟,潘频华,施毅,林其昌,陈一强,倪语星*,谢灿茂*. 头孢哌酮/舒巴坦与亚胺培南/西司他丁和哌拉西林/他唑巴坦治疗革兰阴性菌感染的药物经济学评价.中华医院感染学杂志. 2017; 27(15): 3385-3391.
13
刘颖梅#,刘智博,黎斌斌,王春雷,张武,曹彬*. 非巴西和星形奴卡菌肺部感染七例临床特征分析. 中华结核和呼吸杂志. 2017, 7; 40(7): 543-545.
14
周飞#,王业明,周蕾,李辉,曹彬*. 人感染H7N9禽流感诊疗方案(2017年第一版)解读. 中华结核和呼吸杂志. 2017, 8; 40(8): 584-587.
15
薛春雪#,温铭杰,刘萌,张须龙*,曹彬*. γδT17/Th17/Tc17细胞在H1N1重症感染小鼠肺脏中的分布及其与肺脏免疫损伤的关系. 中国免疫学杂志. 2017, 4; 33(4): 563-568.
16
王业明#,曹彬*. C5a在中性粒细胞介导的重症社区获得性肺炎相关急性肺损伤中的作用.中华结核和呼吸杂志. 2017, 4; 40(4): 297-299.